Awareness of Right to Treatment Programs
“You can do anything you decide to do. You can act to change and control your life. . . .”
We’re rolling out our platform of Right to Try treatment programs at Access Hope CRO. However, there are some limitations on how and when we can disseminate information about them to patients, their caregivers, and doctors. I thought it might be helpful to explain how the process works, and why we have set it up the way we have.
Right to Try (RTT) is a new federal law meant to expand the population of patients with access to drugs in FDA-approved clinical trials, outside of those trials. The new law defines eligible patients and eligible drugs, and then allows licensed physicians to treat properly-informed and consented patients with these treatments, outside of the traditional FDA clinical trial process. To make this at all workable, RTT exempts everyone involved in the process from a myriad FDA rules and regulations. However, some regulations remain. The most meaningful of these is that you still may not promote an unapproved drug.
The number and type of programs that we run will change constantly as we add new ones. Once you’ve opted in to the AHCRO database, we can tell you if there is a program for you now. We can also contact you if there’s a match in the future. You don’t need to do anything more. But we can’t do any of this if you are not in our data base.
Amelia Earhart also said, “the most difficult thing is the decision to act, the rest is mere tenacity.”